drugset / Trial / NCT02026921
A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
A phase II single arm study of carboplatin and docetaxel in treatment of first sensitive relapse of epithelial ovarian, peritoneal or tubal cancer. Hypothesis: Treatment with this combination in second line is safe and with a low frequency of neurologic side effect.
Timeline
- Start
- 2004-06
- Primary completion
- 2006-03
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 5 unknown | Intravenous |
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |